Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney.

C. Lacombe, J L Da Silva, Patrick Bruneval, +7

Journal of Clinical Investigation

HistocompatibilityImmunologyRenal InflammationImmunophenotypingBlood Cell +17

The resolved layer of a collisionless, high β, supercritical, quasi‐perpendicular shock wave: 1. Rankine‐Hugoniot geometry, currents, and stationarity

J. D. Scudder, A. Mangeney, C. Lacombe, +6

Journal of Geophysical Research Atmospheres

EngineeringFluid MechanicsPlasma PhysicsWave MotionSpace Plasma Physic +17

First results obtained by the Cluster STAFF experiment

N. Cornilleau‐Wehrlin, G. Chanteur, S. Perraut, +20

Annales Geophysicae

Cluster ComputingCluster DevelopmentGeospace PhysicsEngineeringPhysics +13

Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation.

Stéphanie Gobert, Stany Chrétien, Fabrice Gouilleux, +7

The EMBO Journal

PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML

Sophie Park, Nicolas Chapuis, Valérie Bardet, +12

Leukemia

Dual InhibitorHematological MalignancyMedicineAntileukemic ActivityMixed-phenotype Acute Leukemia +9

The Cluster Spatio-Temporal Analysis of Field Fluctuations (STAFF) Experiment

N. Cornilleau‐Wehrlin, P. Chauveau, Sony Achmad Louis, +20

Space Science Reviews

MeasurementSpatio-temporal ModelSpatiotemporal OrganizationShort-term VariabilityStatistics +2

WIND observations of coherent electrostatic waves in the solar wind

A. Mangeney, C. S. Salem, C. Lacombe, +7

Annales Geophysicae

Solar Plasma PhysicsEngineeringPhysicsAtmospheric ScienceSolar Convection +12

The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia

Lise Willems, Nicolas Chapuis, Alexandre Puissant, +18

Leukemia

Hematological MalignancyTumor BiologyDual Mtorc1MedicineAcute Myeloid Leukemia +8

Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody

Nicolas Chapuis, Jérôme Tamburini, Pascale Cornillet‐Lefèbvre, +10

Haematologica

High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells

Laury Poulain, Pierre Sujobert, Florence Zylbersztejn, +23

Leukemia

Hematological MalignancyMolecular PharmacologyG6pd InhibitionGlycolysis AddictionMedicine +7